TN2013000433A1 - Therapeutic nuclease compositions and methods - Google Patents

Therapeutic nuclease compositions and methods

Info

Publication number
TN2013000433A1
TN2013000433A1 TNP2013000433A TN2013000433A TN2013000433A1 TN 2013000433 A1 TN2013000433 A1 TN 2013000433A1 TN P2013000433 A TNP2013000433 A TN P2013000433A TN 2013000433 A TN2013000433 A TN 2013000433A TN 2013000433 A1 TN2013000433 A1 TN 2013000433A1
Authority
TN
Tunisia
Prior art keywords
methods
therapeutic nuclease
nuclease compositions
compositions
therapeutic
Prior art date
Application number
TNP2013000433A
Other languages
French (fr)
Inventor
Jeffrey A Ledbetter
Martha Hayden-Ledbetter
Keith Elkon
Xizhang Sun
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2012/035614 external-priority patent/WO2012149440A2/en
Application filed by Univ Washington filed Critical Univ Washington
Publication of TN2013000433A1 publication Critical patent/TN2013000433A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
TNP2013000433A 2012-03-29 2013-10-24 Therapeutic nuclease compositions and methods TN2013000433A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261617241P 2012-03-29 2012-03-29
PCT/US2012/035614 WO2012149440A2 (en) 2011-04-29 2012-04-27 Therapeutic nuclease compositions and methods

Publications (1)

Publication Number Publication Date
TN2013000433A1 true TN2013000433A1 (en) 2015-03-30

Family

ID=54359589

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000433A TN2013000433A1 (en) 2012-03-29 2013-10-24 Therapeutic nuclease compositions and methods

Country Status (1)

Country Link
TN (1) TN2013000433A1 (en)

Similar Documents

Publication Publication Date Title
MX2021015735A (en) Therapeutic nuclease compositions and methods.
MX2018013333A (en) Therapeutic nuclease compositions and methods.
HK1203566A1 (en) Methods and compositions for treating huntingtons disease
HK1209021A1 (en) Nanotherapeutics for drug targeting
PL2672966T3 (en) Pharmaceutical composition, methods for treating and uses thereof
ZA201500021B (en) Methods and compositions for improving gut microbiota population
RS61827B1 (en) Pharmaceutical composition, methods for treating and uses thereof
IL225597A0 (en) Pharmaceutical composition, methods for treating and uses thereof
HRP20180687T1 (en) Compositions and methods for treating celiac sprue disease
HK1199831A1 (en) Composition for improving and or treating central nervous system degenerative disease
EP2709614A4 (en) Pharmaceutical compositions and methods for treating cancer
MX357284B (en) Quinone compounds for treating ape1 mediated diseases.
PH12015500663A1 (en) Pharmaceutical combinations comprising dual angiopoietin-2/dll4 binders and anti-vegf-r agents
EP2872166A4 (en) Compositions and methods for detecting, treating and preventing diseases and disorders
SG11201400976WA (en) Methods and pharmaceutical compositions for treating cancer
WO2013163562A3 (en) Compositions and methods for treating ptsd and related diseases
BR112014032456A2 (en) in vitro methods, pharmaceutical composition, method kit and method for improving the treatment effect
TN2013000433A1 (en) Therapeutic nuclease compositions and methods
TR201819137T4 (en) Therapeutic nuclease compositions and methods.
EP2902027A4 (en) Drug composition for treating tumors and application thereof
MX350868B (en) MEDICAMENTS and METHODS FOR TREATING CANCER.
TN2014000207A1 (en) Anti il-36r antibodies